Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial. - Wikidata - wikimedia - TriplyDB

Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.

Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.

http://www.wikidata.org/entity/Q35906004

about

Genistein and cancer: current status, challenges, and future directions Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors Effective Anti-aging Strategies in an Era of Super-aging Botanicals and Their Bioactive Phytochemicals for Women's Health Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature Dietary components and uterine leiomyomas: a review of published data.The potential health effects of dietary phytoestrogens Evidence of lifestyle modification in the management of hypercholesterolemia.A real-time fluorescence polarization activity assay to screen for inhibitors of bacterial ribonuclease P Soy, red clover, and isoflavones and breast cancer: a systematic review Endogenous and exogenous hormone exposure and the risk of meningioma in men.Therapeutic perspectives of epigenetically active nutrients.Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density.The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G The effects of soy supplementation on gene expression in breast cancer: a randomized placebo-controlled study.Soy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein.Cytology in nipple aspirate fluid during a randomized soy food intervention among premenopausal women.The role and place of medicinal plants in the strategies for disease prevention.Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study.Can breast cancer patients use soyafoods to help reduce risk of CHD?Geriatric obesity: evaluating the evidence for the use of flavonoids to promote weight loss.Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks.Multispectral imaging: a review of its technical aspects and applications in anatomic pathology.Hormones, herbal preparations and nutriceuticals for a better life after the menopause: part II.Metabolism and health effects of phyto-estrogens.Genistein and enterolactone in relation to Ki-67 expression and HER2 status in postmenopausal breast cancer patients.In vitro-in silico-based analysis of the dose-dependent in vivo oestrogenicity of the soy phytoestrogen genistein in humans.Glycone-rich Soy Isoflavone Extracts Promote Estrogen Receptor Positive Breast Cancer Cell Growth.Sex hormone modulation of both induction and inhibition of CYP1A by genistein in HepG2/C3A cells.Dietary Natural Products for Prevention and Treatment of Breast Cancer.Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial.Relationship of serum levels and dietary intake of isoflavone, and the novel bacterium Slackia sp. strain NATTS with the risk of prostate cancer: a case-control study among Japanese men.State of the evidence 2017: an update on the connection between breast cancer and the environment Plasma bioavailability and changes in PBMC gene expression after treatment of ovariectomized rats with a commercial soy supplement.The Impacts of Genistein and Daidzein on Estrogen Conjugations in Human Breast Cancer Cells: A Targeted Metabolomics Approach.Gene Methylation and Cytological Atypia in Random Fine-Needle Aspirates for Assessment of Breast Cancer Risk [Dietary isolated isoflavone supplements for peri- and postmenopausal women: risks and questionable benefits].Risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavones Lactobacillus casei Shirota enhances the preventive efficacy of soymilk in chemically induced breast cancer.Antimetabolic Effects of Polyphenols in Breast Cancer Cells: Focus on Glucose Uptake and Metabolism.

P2860

Q26801271-2C38D88E-763E-4EED-8229-F35DEAEACC47 Q26830522-FD57C6C8-1163-4C42-9F51-7A61A9818CE5 Q27001605-C20AF86F-1247-487C-86D4-0AC3ECC3D108 Q28065998-ACE9E396-FF08-4830-B46B-82728BEABC26 Q28071946-2429F219-C5D7-48D6-BBF6-3B8AB3B5A67E Q30920085-80CF908E-8BF4-4070-B163-22B977A881A1 Q33676455-D97A0AD0-AEE6-4859-9BBC-DD94F2D53FF1 Q34301108-238E9D6C-5115-471D-A125-50597E3AA2D8 Q34489660-9B583E12-ED5B-433F-BCE9-5E7B4600D0C1 Q34658148-22B9372E-19B9-4CDB-BFA8-616F0B966175 Q35283987-34B62FF7-B308-4575-A70A-273571DE6933 Q35631468-A10D4690-21E6-401E-9A7F-16DC261F9E98 Q36132748-BE8B1199-B620-4B2E-B38F-FACCC477CAA8 Q36451858-A7B1F849-2C68-4ACE-9075-CA2C1F6B737E Q36754900-F52C4D5E-C67F-4933-A51C-0783452580AF Q37074134-A4EA43E6-7A98-498D-B0B2-C07FA0A14F0B Q37338675-4C81D0B1-0DFB-426F-A00B-F1717D46C7E7 Q37357214-24E5758C-85B9-4263-B90A-3319CC833804 Q37359706-49DF1D11-882D-4752-A1B0-D7F9B18BD11B Q38032972-221B5F42-DA7E-4A30-B1C6-610F7DC04A19 Q38034248-7B65CB01-DA85-4D10-9E4B-E047F01A7B89 Q38061846-5FE148EA-5287-4999-9535-D466FDBC2ACB Q38152999-3AD9735E-BE32-4E4D-84DA-F3A5B865A1BA Q38350780-D697E16E-17B4-4E47-9374-8D83F8D69827 Q38630555-1DE70E26-CE35-431B-AAB7-3528BC906BC5 Q38666974-783A4480-2737-4A56-BC5E-25FD458C5620 Q38741506-CDE1500C-FA23-4C37-90E4-496CF26F247C Q38780897-5C532964-AD96-478F-9C41-F1AEFDD6BC42 Q38931868-E2FF8326-F37A-4EFB-ACE1-F05EDD0A39C6 Q39429454-470DFF26-B6A0-432E-935B-EBFCADE51DE6 Q39485105-9CDE7602-2637-4F0E-8AFD-2593116C3AF8 Q40718691-0BC04B1A-BA66-4489-81C6-A6FA176B9CEA Q41595188-F7203B21-0F0C-4AD5-8109-C6A48360BF2C Q41680668-E6953CEC-F71A-41F1-9B84-F29692619112 Q42373520-A8E6CB52-F09D-4952-9505-C08B307A584C Q42385500-E03DB658-4DA4-4D54-9362-67A6BBE4D8CD Q44536906-12EAD701-3C93-4869-85EF-811BB7271F3D Q47157326-CBD445D3-0768-4157-A4CA-5603FF9ACEDF Q51209873-F837A12E-E71C-4F1B-ABAA-35C594947D77 Q52715290-C34C7E92-80C0-4E91-8290-4653D1686B79

P2860

Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.

http://www.wikidata.org/entity/Q35906004

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Soy isoflavone supplementation ...... : a randomized phase II trial.

@ast

Soy isoflavone supplementation ...... : a randomized phase II trial.

@en

type

label

Soy isoflavone supplementation ...... : a randomized phase II trial.

@ast

Soy isoflavone supplementation ...... : a randomized phase II trial.

@en

prefLabel

Soy isoflavone supplementation ...... : a randomized phase II trial.

@ast

Soy isoflavone supplementation ...... : a randomized phase II trial.

@en

P1433

Q35906004-86B15412-BDF6-4D86-B03A-BB44770ADD6A

P1476

Q35906004-6F9629DC-2BB9-45E4-9BA2-577E1927AF0C

P2093

Q35906004-24BFC22E-68E4-40B9-A982-07BE1979FACE

Q35906004-37E1BA19-C9AC-4E8C-BFB9-0BDC78D39EDD

Q35906004-40FA267E-3EC8-42B6-AD87-2C2438700931

Q35906004-477D0C1B-A7C2-4B23-9C6A-9BA5A8F5568B

Q35906004-4EA0FDC6-5218-43DA-B9A0-399EDB5DBFF7

Q35906004-6DA8C1D8-6237-49B7-9443-B1F43799DB04

Q35906004-6FEDE983-41B9-4A30-9C1D-1453F251538A

Q35906004-772D8F49-B3C6-4C73-8932-55E450010CCF

Q35906004-9CFB26CC-5D69-4328-B166-16323621D264

Q35906004-A4938C1A-A5D4-4CE7-BC57-7BC604EF048B

P2860

Q35906004-0E1BD0D1-D7A4-4EFB-838A-052DCE805D77

Q35906004-0ECF298A-24A0-4AFA-9F6F-A4AD0AA4AA1C

Q35906004-18C9AB3C-ADD6-4228-83D9-C8AF90408986

Q35906004-2D2E82B5-95B4-46EA-98D6-024EFA70EF5B

Q35906004-3299AF06-299A-49B3-AAF8-482EB8F10EEC

Q35906004-3A2CF711-1282-498A-8059-117AF29D6D8A

Q35906004-4AD264E1-1C0E-43E2-89E5-36BF7D175159

Q35906004-4E3957F0-FCB2-4A50-B47B-69CC351302C1

Q35906004-4F71C36E-1F68-4EEF-9FC1-47D51702EFA5

Q35906004-5253FFB1-CBD9-4749-801F-6B370599AF9B

P304

Q35906004-13F03995-55B6-4A0E-AB5F-96270E878AA7

P31

Q35906004-F4E2B172-BABA-483B-B348-4A2AB1DF23CB

P356

Q35906004-85D11F71-8B4C-4226-B981-2A9F4CE2C636

P433

Q35906004-C1168A6A-D8C4-4112-BDDA-75AFA2ABCBAF

P478

Q35906004-463A6C91-DE39-41C7-BFA9-E41838301CA5

P50

Q35906004-06D53567-FF63-4553-B1A0-34C310953B73

Q35906004-97CC8BFE-FF2D-45E9-800F-5EE017C8C0CE

P577

Q35906004-C40D1709-A230-4D89-B11A-2B7945BF1D4E

P698

Q35906004-73ABA0B4-7563-453A-AC04-921C8AA3E3A2

P921

Q35906004-C587F769-C7EE-4D89-9ED7-2B805DBAA81A

P932

Q35906004-0A82B921-1C9F-46E6-8337-DB22933CFF18

P356

1940-6207.CAPR-11-0251

P1433

Cancer Prevention Research

P1476

Soy isoflavone supplementation ...... n: a randomized phase II trial

@en

P2093

Adrian A Franke

http://www.w3.org/2001/XMLSchema#string

Alexander Dew

http://www.w3.org/2001/XMLSchema#string

Borko D Jovanovic

http://www.w3.org/2001/XMLSchema#string

Carola M Zalles

http://www.w3.org/2001/XMLSchema#string

David Ivancic

http://www.w3.org/2001/XMLSchema#string

Irene B Helenowski

http://www.w3.org/2001/XMLSchema#string

Kevin P Bethke

http://www.w3.org/2001/XMLSchema#string

Maarten C Bosland

http://www.w3.org/2001/XMLSchema#string

Margerie Coomes

http://www.w3.org/2001/XMLSchema#string

Michelle Bryk

http://www.w3.org/2001/XMLSchema#string

P2860

Soy food intake and breast cancer survival

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

Method of defining equol-producer status and its frequency among vegetarians

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

Gene expression profiles of human breast cancer progression.

Childhood soy intake and breast cancer risk in Asian American women.

Dietary genistin stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein.

Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies.

Soy product and isoflavone consumption in relation to prostate cancer in Japanese men.

Hormonal changes in the menopause transition.

P304

309-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1940-6207.CAPR-11-0251

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22307566

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

P932

3333836

http://www.w3.org/2001/XMLSchema#string